Department of Medical Oncology, Tom Baker Cancer Center, Calgary, Alberta, Canada.
Cumming School of Medicine, Department of Oncology, University of Calgary, 1331 - 29 Street NW, Calgary, Alberta, T2N 4N2, Canada.
Support Care Cancer. 2021 Jun;29(6):3299-3309. doi: 10.1007/s00520-020-05827-w. Epub 2020 Oct 26.
Patients dying with cancer can experience various physical and psychological symptoms. We aimed to determine the type and severity of symptoms within the last 6 months of life in a large real-world cohort of patients with cancer.
We examined prospectively collected patient-reported outcomes of patients with lung, colorectal, breast, prostate or pancreatic cancer using the revised Edmonton Symptom Assessment System (ESASr) questionnaire from a large province in Canada from 2016 to 2017. The ESASr was categorized into physical and psychological symptom subscores and total symptom score, and each was classified as none to mild (0-3) or moderate to severe (4-10) based on intensity. Multivariable logistic regression analyses were performed to evaluate the relationship between clinical characteristics and symptom scores.
We identified 1159 patients eligible for analysis, of whom 52.2% were men and median age was 68 years. There were 613, 192, 149, 111 and 94 patients with lung, colorectal, breast, prostate and pancreatic cancer, respectively. While approximately half of patients reported moderate to severe physical symptom subscores and total symptom scores, only one-third reported moderate to severe psychological subscores. On multivariable logistic regression analyses, women were more likely to report moderate to severe physical (odds ratio [OR], 1.52; 95% confidence interval [CI], 1.08-2.12; P = 0.016), psychological (OR, 1.60; 95% CI, 1.14-2.26; P = 0.006) and total symptom scores (OR, 1.80; 95% CI, 1.28-2.51; P = 0.001). Patients with lung cancer were also more likely to report moderate to severe physical and psychological subscores (OR, 1.95; 95% CI, 1.28-2.96; P = 0.002 and OR, 1.78; 95% CI, 1.13-2.81; P = 0.013) and total symptom scores (OR, 1.83; 95% CI, 1.20-2.81; P = 0.005). Finally, those closer to death were more likely to report moderate to severe physical symptom subscores (OR, 2.07; 95% CI, 1.33-3.23; P = 0.001) and total symptom scores (OR, 2.29; 95% CI, 1.46-3.60; P < 0.001), but not psychological symptom scores (OR, 1.34; 95% CI, 0.84-2.14; P = 0.210).
There is significant symptom burden in patients with cancer near the end-of-life. Further, physical symptoms appear to be more intense than psychological symptoms. Symptom-directed care is still needed to improve the quality of end-of-life.
临终癌症患者可能会经历各种身体和心理症状。我们旨在确定在加拿大一个大省 2016 年至 2017 年期间,使用修订后的埃德蒙顿症状评估系统(ESASr)问卷的大量癌症患者在生命的最后 6 个月内的症状类型和严重程度。
我们使用来自加拿大一个大省的前瞻性收集的肺癌、结直肠癌、乳腺癌、前列腺癌或胰腺癌患者的患者报告结局,使用修订后的埃德蒙顿症状评估系统(ESASr)问卷进行了检查。ESASr 分为身体和心理症状子评分和总症状评分,并根据强度分为无到轻度(0-3)或中度到重度(4-10)。采用多变量逻辑回归分析评估临床特征与症状评分之间的关系。
我们确定了 1159 名符合分析条件的患者,其中 52.2%为男性,中位年龄为 68 岁。有 613、192、149、111 和 94 名患者患有肺癌、结直肠癌、乳腺癌、前列腺癌和胰腺癌,分别。尽管约一半的患者报告了中度至重度的身体症状子评分和总症状评分,但只有三分之一的患者报告了中度至重度的心理子评分。多变量逻辑回归分析表明,女性更有可能报告中度至重度的身体(比值比[OR],1.52;95%置信区间[CI],1.08-2.12;P=0.016)、心理(OR,1.60;95%CI,1.14-2.26;P=0.006)和总症状评分(OR,1.80;95%CI,1.28-2.51;P=0.001)。肺癌患者也更有可能报告中度至重度的身体和心理子评分(OR,1.95;95%CI,1.28-2.96;P=0.002 和 OR,1.78;95%CI,1.13-2.81;P=0.013)和总症状评分(OR,1.83;95%CI,1.20-2.81;P=0.005)。最后,那些接近死亡的患者更有可能报告中度至重度的身体症状子评分(OR,2.07;95%CI,1.33-3.23;P=0.001)和总症状评分(OR,2.29;95%CI,1.46-3.60;P<0.001),但不是心理症状评分(OR,1.34;95%CI,0.84-2.14;P=0.210)。
临终癌症患者的症状负担明显。此外,身体症状似乎比心理症状更严重。仍然需要针对症状的护理,以提高临终关怀的质量。